Centerpulse half-year net income doubles
This article was originally published in Clinica
Centerpulse has seen its net income before exceptional items more than double to SFr94.8m ($63m) in the first six months of 2002, with sales up 6% to SFr766.4m. The company, which has spent much of the past 18 months attempting to settle litigation relating to faulty hip and knee products, has also made personnel changes. These are aimed in part at managing the company's planned divestment of the cardiac and vascular divisions, which it hopes to achieve by the end of this year.
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.